Ana Rita Rodrigues on the Impact of Post-Stroke Dysphagia
Ana Rita Rodrigues, Revisor for Health Science Reports at Wiley, shared on LinkedIn:
”Very pleased to see our work on the impact of post-stroke dysphagia highlighted, carried out at the Unidade Local de Saúde de Matosinhos and published in the Revista Portuguesa de Otorrinolaringologia e Cirurgia da Cabeça e Pescoço.
This study — of which I am the first author — analysed 137 patients assessed with fiberoptic endoscopic evaluation of swallowing (FEES) between 2018 and 2023, showing how dysphagia in the acute phase after stroke influences functional prognosis, length of hospital stay, and the risk of respiratory complications.
It is very gratifying to see this highly relevant topic featured by the My Otorrino platform, helping to raise awareness of the importance of early diagnosis and intervention.
A special thank you to the entire multidisciplinary team for their daily commitment to caring for patients with dysphagia.”
Read the full article here.
Article: Clinical and functional impact of oropharyngeal dysphagia after stroke: a retrospective study
Authors: Ana Rita Rodrigues, Adelaide Dias, Delfim Duarte, Nuno Oliveira
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 11, 2026, 18:27Cesar Garrido and Lackram Bodoe Are Advancing WFH Partnerships in Trinidad and Tobago
-
Mar 11, 2026, 18:14Aloke Finn: Silent Plaque Rupture and Healing in Coronary Artery Disease
-
Mar 11, 2026, 17:23Mattia Galli: A Privilege to Collaborate on Such a Complex Topic as Cardio-Rheumatology
-
Mar 11, 2026, 17:12Shubham Misra: Proteomic Biomarkers for Acute Stroke Subtype Classification
-
Mar 11, 2026, 16:55Melanie Daniel: Modeling High-Purity von Willebrand Factor for Individualized Dosing in Surgery
-
Mar 11, 2026, 15:46Bleeding and Thrombosis Outcomes in Older Patients With Myelodysplastic Syndromes – JTH
-
Mar 11, 2026, 15:37Sonia Muliyil: The Greatest Benefit is The Wellbeing and Sustenance of Half The World’s Population
-
Mar 11, 2026, 15:34Kymentie Ferdinande: Rivaroxaban in Cirrhosis and the Path Toward Individualized Anticoagulation
-
Mar 11, 2026, 15:34Sheharyar Raza: When More Testing Isn’t Always Better in Healthy Donor Screening